Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.420
-0.030 (-1.22%)
Apr 2, 2026, 1:51 PM EDT - Market open
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $140.1 million as of April 2, 2026. Its market cap has increased by 241.70% in one year.
Market Cap
140.10M
Enterprise Value
104.46M
1-Year Change
241.70%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $140.10M, a decrease of -9.09%. That is a compound annual growth rate of -1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 141.80M | 8.00% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Heron Therapeutics | 151.49M |
| Immunic | 150.03M |
| Tenaya Therapeutics | 147.78M |
| Cibus | 147.01M |
| Precision BioSciences | 146.82M |
| Molecular Partners AG | 145.52M |
| Fate Therapeutics | 144.17M |
| Kalaris Therapeutics | 135.74M |